Volume 54, Issue 4, Pages (October 2008)

Slides:

Advertisements

Similar presentations

Fig F-fluoride positron emission tomography (PET) in atherosclerosis

Advertisements

Volume 64, Issue 5, Pages (November 2013)

Volume 72, Issue 3, Pages (September 2017)

The PSA Era is not Over for Prostate Cancer

Volume 64, Issue 6, Pages (December 2013)

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 70, Issue 4, Pages (October 2016)

Volume 60, Issue 4, Pages (October 2011)

Testosterone Therapy in Men With Prostate Cancer

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

Volume 70, Issue 1, Pages (July 2016)

Volume 60, Issue 4, Pages (October 2011)

Volume 61, Issue 5, Pages (May 2012)

Volume 73, Issue 5, Pages (May 2018)

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.

Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique Sevan Stepanian, Mayank Patel, James.

Volume 64, Issue 4, Pages (October 2013)

Volume 69, Issue 1, Pages (January 2016)

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography Walter.

Volume 64, Issue 6, Pages (December 2013)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 70, Issue 4, Pages (October 2016)

Volume 64, Issue 5, Pages (November 2013)

18F-Sodium Fluoride PET–CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma Stefania Gori, MD, Alessandro Inno, MD, PhD, Gianluigi Lunardi,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Volume 65, Issue 4, Pages (April 2014)

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Volume 62, Issue 1, Pages (July 2012)

Volume 57, Issue 2, Pages (February 2010)

Counselling the Prostate Cancer Patient

Prostate Cancer Epidemic in Sight?

Volume 48, Issue 4, Pages (October 2005)

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,

Volume 66, Issue 2, Pages (August 2014)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Tillmann Loch, Pat Fox Fulgham European Urology

PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies Steven P. Rowe, Kenneth J.

Volume 71, Issue 6, Pages (June 2017)

A Case of Renal Capsular Liposarcoma with Intracaval Fat Thrombus

Volume 50, Issue 5, Pages (November 2006)

Volume 53, Issue 1, Pages (January 2008)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography Gustaf Tegler, MD, Jens Sörensen,

Interest of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of relapse in patients with spinal infection: a.

When is it Best to Repeat a 2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer.

Testicular Cancer Variations in Time and Space in Europe

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

European Urology is “Your” Journal

European Urology Oncology

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Volume 50, Issue 5, Pages (November 2006)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy Yelena.

Volume 52, Issue 2, Pages (August 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 51, Issue 2, Pages (February 2007)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 54, Issue 4, Pages 938-941 (October 2008) Durable Complete Response to Frontline Docetaxel in an Advanced Prostate Cancer Patient with Favourable CYP1B1 Isoforms: Suggestion for Changing Paradigms? Giovanni Brandi, Francesco de Rosa, Romano Danesi, Gian Carlo Montini, Guido Biasco European Urology Volume 54, Issue 4, Pages 938-941 (October 2008) DOI: 10.1016/j.eururo.2008.07.029 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 11C-choline positron-emission tomography/computed tomography (PET/CT) performed after surgery showing a high tracer uptake area in the prostatic lodge (yellow in the fusion image on the left), strongly suggestive of residual disease. European Urology 2008 54, 938-941DOI: (10.1016/j.eururo.2008.07.029) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 2 11C-choline positron-emission tomography/computed tomography (PET/CT) performed after surgery, sagittal section; a high tracer uptake area is shown (centre of the yellow cross), corresponding to a lumbar aortic lymph node. This finding is strongly suggestive of disease presence in a lymph node not removed during the surgical procedure. European Urology 2008 54, 938-941DOI: (10.1016/j.eururo.2008.07.029) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 3 11C-choline positron-emission tomography/computed tomography (PET/CT) performed after docetaxel therapy, same section as Fig. 1. The high tracer uptake area previously identified in the prostatic lodge has disappeared. European Urology 2008 54, 938-941DOI: (10.1016/j.eururo.2008.07.029) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 4 11C-choline positron-emission tomography/computed tomography (PET/CT) performed after docetaxel therapy, same section as Fig. 2. The high tracer uptake area previously identified, corresponding to a lumbar aortic lymph node, has disappeared. European Urology 2008 54, 938-941DOI: (10.1016/j.eururo.2008.07.029) Copyright © 2008 European Association of Urology Terms and Conditions